Medical Device Network·3 min read·hard

New AHA report highlights Ultromics’ AI tool’s benefit in earlier heart failure diagnosis

R
Ross Law
New AHA report highlights Ultromics’ AI tool’s benefit in earlier heart failure diagnosis
AI Summary

A new report from the American Heart Association indicates that Ultromics' EchoGo AI tool can detect heart failure with preserved ejection fraction up to nine months earlier than standard care. The tool automates echocardiogram analysis to improve diagnostic accuracy and reduce manual errors.

The AHA’s Impact Report was created using independent clinical and image data through its AI Assessment Lab.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
technologyhealthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in